Abstract:Early detection of cancer is crucial to reducing fatalities and improving patient outcomes. Metastasis is the first stage of aggressive cancers, often occurring before primary lesions can be seen. It occurs when cancerous cells disseminate to distant, non-malignant organs through the bloodstream, known as circulating tumor cells (CTCs). CTCs, or cancer tumor cells, are valuable indicators for predicting treatment response, metastasis progression, and disease progression. However, they are primarily used for research due to challenges like heterogeneity, separation from blood, and lack of clinical validation. Only a few methods have been approved for clinical use. One area of research is the isolation and identification of CTCs, which could significantly impact early cancer detection and prognosis. Current technologies using whole-blood samples use size, immunoaffinity, and density approaches, along with positive and negative enrichment techniques. Surface modification of nanomaterials is important for effective cancer therapies because it improves their ability to target and reduces interactions with healthy tissues. Consequently, researchers have created biomimetic nanoparticles covered with cell membranes using functional, targeted, and biocompatible coating technology. Nanoparticles with membranes can target specific cells, stay in circulation for longer, and avoid immune responses, which makes them much better at capturing CTCs. This study examines the current opportunities and difficulties associated with using cell membrane–coated nanoparticles as a capture technique for CTCs. In addition, we examine potential future developments in light of the current obstacles and investigate areas that require further research to fully understand its growing clinical possibilities.

A Novel Cell Membrane-Associated RNA Extraction Method and Its Application in the Discovery of Breast Cancer Markers

A PCR-free Screen-Printed Magnetic Electrode for the Detection of Circular RNA from Hepatocellular Cancer Based on a Back-Splice Junction

A Fishhook Probe-Based Rolling Circle Amplification (FP-RCA) Assay for Efficient Isolation and Detection of Microrna Without Total RNA Extraction.

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

An Integrated Electrochemical Nanodevice for Intracellular RNA Collection and Detection in Single Living Cell.

Identification of Molecular Profile of Cell Membrane via Magnetic Plasmonic Nanoprobe

Emerging Sensing and In Situ Detection Technologies for the Analysis of Extracellular Vesicle miRNAs

In Situ , Fusion-Free, Multiplexed Detection of Small Extracellular Vesicle miRNAs for Cancer Diagnostics

Erythrocyte Membrane-Biointerfaced Spherical Nucleic Acids: Robust Performance for Microrna Quantification.

Rapid Exosome Isolation and in Situ Multiplexed Detection of Exosomal Surface Proteins and Micrornas on Microfluidic Platform

RNA Biomarkers: Frontier of Precision Medicine for Cancer.

Research progress of cell membrane biomimetic nanoparticles for circulating tumor cells

Ultrasensitive miRNA detection: A novel DNA nanomachine using split-type molecular beacons-mediated cascade amplification for cancer diagnostics

MEMO: A Micro Memo Sensor Detecting microRNA-RISC using an Accurate Cell-Free Expression Platform

Simultaneous Detection of Exosomal Membrane Protein and RNA by Highly Sensitive Aptamer Assisted Multiplex-PCR.

A Novel Dual Energy Transfer Probe for Intracellular Mrna Detection with High Robustness and Specificity

DNA–Gold Nanoparticle Conjugates for Intracellular miRNA Detection Using Surface-Enhanced Raman Spectroscopy

A pH-Mediated Highly Selective System Enabling Simultaneous Analysis of Circulating RNAs Carried by Extracellular Vesicles and Lipoproteins

Breast Cancer Plasma Biopsy by in Situ Determination of Exosomal Microrna-1246 with a Molecular Beacon.

Magnetic bead-based adsorption strategy for exosome isolation

All-in-One Fusogenic Nanoreactor for the Rapid Detection of Exosomal MicroRNAs for Breast Cancer Diagnosis